Oscar Health, Inc. (NYSE:OSCR) Receives $20.21 Consensus Price Target from Analysts

Oscar Health, Inc. (NYSE:OSCRGet Free Report) has earned an average recommendation of “Hold” from the eight analysts that are presently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a sell recommendation, three have issued a hold recommendation, two have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month target price among brokerages that have issued a report on the stock in the last year is $20.21.

Several equities research analysts have commented on OSCR shares. Jefferies Financial Group initiated coverage on Oscar Health in a research note on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price target for the company. Wells Fargo & Company downgraded shares of Oscar Health from an “overweight” rating to an “equal weight” rating and dropped their target price for the stock from $20.00 to $16.00 in a research report on Thursday, March 13th.

View Our Latest Analysis on OSCR

Institutional Investors Weigh In On Oscar Health

Several hedge funds have recently modified their holdings of OSCR. Summit Investment Advisors Inc. increased its stake in Oscar Health by 5.8% during the 4th quarter. Summit Investment Advisors Inc. now owns 20,838 shares of the company’s stock worth $280,000 after buying an additional 1,141 shares during the period. Arizona State Retirement System increased its position in shares of Oscar Health by 3.1% in the 4th quarter. Arizona State Retirement System now owns 47,918 shares of the company’s stock worth $644,000 after purchasing an additional 1,454 shares during the last quarter. Xponance Inc. lifted its position in shares of Oscar Health by 12.9% during the fourth quarter. Xponance Inc. now owns 14,394 shares of the company’s stock worth $193,000 after purchasing an additional 1,649 shares during the last quarter. Wealth Enhancement Advisory Services LLC lifted its holdings in Oscar Health by 15.2% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 13,862 shares of the company’s stock worth $186,000 after buying an additional 1,834 shares during the last quarter. Finally, California State Teachers Retirement System boosted its holdings in Oscar Health by 1.2% in the fourth quarter. California State Teachers Retirement System now owns 156,901 shares of the company’s stock worth $2,109,000 after purchasing an additional 1,846 shares during the period. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Oscar Health Price Performance

Oscar Health stock opened at $13.29 on Friday. Oscar Health has a 1 year low of $12.43 and a 1 year high of $23.79. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The firm has a 50 day moving average price of $14.90 and a 200 day moving average price of $16.05. The company has a market cap of $3.33 billion, a price-to-earnings ratio of -663.92 and a beta of 1.75.

Oscar Health (NYSE:OSCRGet Free Report) last announced its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. Sell-side analysts predict that Oscar Health will post 0.69 earnings per share for the current year.

About Oscar Health

(Get Free Report

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

See Also

Analyst Recommendations for Oscar Health (NYSE:OSCR)

Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.